FineMark National Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-428
| Closed | -$208K | – | 468 |
|
|
2025
Q1 | $208K | Buy |
+428
| New | +$208K | 0.01% | 414 |
|
|
2024
Q3 | – | Sell |
-428
| Closed | -$201K | – | 436 |
|
|
2024
Q2 | $201K | Sell |
428
-388
| -48% | -$182K | 0.01% | 407 |
|
|
2024
Q1 | $341K | Buy |
+816
| New | +$341K | 0.01% | 334 |
|
|
2023
Q3 | – | Sell |
-845
| Closed | -$297K | – | 438 |
|
|
2023
Q2 | $297K | Buy |
+845
| New | +$297K | 0.01% | 348 |
|
|
2017
Q1 | – | Sell |
-300
| Closed | -$22K | – | 989 |
|
|
2016
Q4 | $22K | Hold |
300
| – | – | ﹤0.01% | 807 |
|
|
2016
Q3 | $26K | Sell |
300
-15
| -5% | -$1.3K | ﹤0.01% | 759 |
|
|
2016
Q2 | $27K | Buy |
315
+15
| +5% | +$1.29K | ﹤0.01% | 764 |
|
|
2016
Q1 | $24K | Hold |
300
| – | – | ﹤0.01% | 752 |
|
|
2015
Q4 | $38K | Sell |
300
-20
| -6% | -$2.53K | ﹤0.01% | 665 |
|
|
2015
Q3 | $33K | Buy |
320
+20
| +7% | +$2.06K | ﹤0.01% | 743 |
|
|
2015
Q2 | $37K | Sell |
300
-200
| -40% | -$24.7K | ﹤0.01% | 737 |
|
|
2015
Q1 | $59K | Buy |
500
+200
| +67% | +$23.6K | 0.01% | 623 |
|
|
2014
Q4 | $36K | Hold |
300
| – | – | 0.01% | 762 |
|
|
2014
Q3 | $34K | Hold |
300
| – | – | 0.01% | 744 |
|
|
2014
Q2 | $28K | Hold |
300
| – | – | ﹤0.01% | 807 |
|
|
2014
Q1 | $21K | Hold |
300
| – | – | ﹤0.01% | 878 |
|
|
2013
Q4 | $22K | Hold |
300
| – | – | ﹤0.01% | 810 |
|
|
2013
Q3 | $23K | Sell |
300
-104
| -26% | -$7.97K | 0.01% | 761 |
|
|
2013
Q2 | $32K | Buy |
+404
| New | +$32K | 0.01% | 660 |
|